Twelve-month mental health service use in six countries of the Americas: A regional report from the World Mental Health Surveys.
Adolescent
Adult
Aged
Anxiety Disorders
/ epidemiology
Argentina
/ epidemiology
Attention Deficit Disorder with Hyperactivity
/ epidemiology
Bipolar Disorder
/ epidemiology
Brazil
/ epidemiology
Colombia
/ epidemiology
Disruptive, Impulse Control, and Conduct Disorders
/ epidemiology
Educational Status
Facilities and Services Utilization
Female
Health Services Accessibility
Humans
Income
Male
Mental Disorders
/ epidemiology
Mental Health Services
/ statistics & numerical data
Mexico
/ epidemiology
Middle Aged
Mood Disorders
/ epidemiology
Peru
/ epidemiology
Practice Guidelines as Topic
Quality of Health Care
Severity of Illness Index
Substance-Related Disorders
/ epidemiology
United States
/ epidemiology
Young Adult
Epidemiology
mental health
service use
transcultural
Journal
Epidemiology and psychiatric sciences
ISSN: 2045-7979
Titre abrégé: Epidemiol Psychiatr Sci
Pays: England
ID NLM: 101561091
Informations de publication
Date de publication:
27 Aug 2019
27 Aug 2019
Historique:
pubmed:
28
8
2019
medline:
20
5
2020
entrez:
28
8
2019
Statut:
epublish
Résumé
To provide cross-national data for selected countries of the Americas on service utilization for psychiatric and substance use disorders, the distribution of these services among treatment sectors, treatment adequacy and factors associated with mental health treatment and adequacy of treatment. Data come from data collected from 6710 adults with 12 month mental disorder surveys across seven surveys in six countries in North (USA), Central (Mexico) and South (Argentina, Brazil, Colombia, Peru) America who were interviewed 2001-2015 as part of the World Health Organization (WHO) World Mental Health (WMH) Surveys. DSM-IV diagnoses were made with the WHO Composite International Diagnostic Interview (CIDI). Interviews also assessed service utilization by the treatment sector, adequacy of treatment received and socio-demographic correlates of treatment. Little over one in four of respondents with any 12 month DSM-IV/CIDI disorder received any treatment. Although the vast majority (87.1%) of this treatment was minimally adequate, only 35.3% of cases received treatment that met acceptable quality guidelines. Indicators of social-advantage (high education and income) were associated with higher rates of service use and adequacy, but a number of other correlates varied across survey sites. These results shed light on an enormous public health problem involving under-treatment of common mental disorders, although the problem is most extreme among people with social disadvantage. Promoting services that are more accessible, especially for those with few resources, is urgently needed.
Identifiants
pubmed: 31452485
doi: 10.1017/S2045796019000477
pii: S2045796019000477
pmc: PMC8061239
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e53Références
Rev Peru Med Exp Salud Publica. 2014;31(1):30-8
pubmed: 24718524
Epidemiol Psychiatr Sci. 2017 Feb;26(1):89-101
pubmed: 27066821
JAMA. 2004 Jun 2;291(21):2581-90
pubmed: 15173149
Am J Psychiatry. 2006 Aug;163(8):1371-8
pubmed: 16877649
Am Psychol. 2003 Jan;58(1):5-14
pubmed: 12674814
Aust N Z J Psychiatry. 2008 Jan;42(1):24-9
pubmed: 18058440
Am J Public Health. 2002 Jan;92(1):92-8
pubmed: 11772769
Am J Psychiatry. 1997 Apr;154(4 Suppl):1-63
pubmed: 9090368
Arch Gen Psychiatry. 2005 Jun;62(6):629-40
pubmed: 15939840
Cien Saude Colet. 2011 Dec;16(12):4603-14
pubmed: 22124901
Am J Psychiatry. 1998 May;155(5 Suppl):1-34
pubmed: 9585731
JAMA. 1995 Jan 4;273(1):51-8
pubmed: 7996651
Psychol Med. 2018 Jul;48(9):1560-1571
pubmed: 29173244
Acta Psychiatr Scand Suppl. 2004;(420):47-54
pubmed: 15128387
JAMA. 2003 Jun 18;289(23):3095-105
pubmed: 12813115
World Psychiatry. 2017 Oct;16(3):299-307
pubmed: 28941090
Lancet. 2015 Aug 22;386(9995):743-800
pubmed: 26063472
Int J Ment Health Syst. 2008 Sep 05;2(1):12
pubmed: 18775070
Am J Psychiatry. 1994 Dec;151(12 Suppl):1-36
pubmed: 7977902
Soc Psychiatry Psychiatr Epidemiol. 2018 Feb;53(2):121-129
pubmed: 29302708
Int J Methods Psychiatr Res. 2004;13(2):93-121
pubmed: 15297906
Clin Psychol Rev. 2016 Nov;49:106-118
pubmed: 27664823
Arch Gen Psychiatry. 2001 Jan;58(1):55-61
pubmed: 11146758
Br J Psychiatry. 2017 Feb;210(2):119-124
pubmed: 27908899
Am J Psychiatry. 2000 Apr;157(4 Suppl):1-45
pubmed: 10767867
Arch Gen Psychiatry. 1976 Jun;33(6):766-71
pubmed: 938196
Lancet. 2007 Sep 8;370(9590):841-50
pubmed: 17826169
Int Clin Psychopharmacol. 1996 Jun;11 Suppl 3:89-95
pubmed: 8923116
Schizophr Bull. 1998;24(1):1-10
pubmed: 9502542
Arch Gen Psychiatry. 1988 Dec;45(12):1069-77
pubmed: 2848472
J Am Acad Child Adolesc Psychiatry. 2018 Apr;57(4):263-273.e1
pubmed: 29588052